WPI 1119 Pill - white oval, 16mm
Pill with imprint WPI 1119 is White, Oval and has been identified as Mirtazapine 45 mg. It is supplied by Watson Pharmaceuticals.
Mirtazapine is used in the treatment of Depression; Major Depressive Disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 1119
Mirtazapine
- Imprint
- WPI 1119
- Strength
- 45 mg
- Color
- White
- Size
- 16.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Tetracyclic antidepressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
polyethylene glycol 400,
polysorbate 80,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-1119 (Discontinued) | Watson Pharmaceuticals, Inc. |
| 63874-1155 (Discontinued) | Altura Pharmaceuticals Inc. (repackager) |
More about mirtazapine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2,023)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: tetracyclic antidepressants
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
